Details for New Drug Application (NDA): 203976
✉ Email this page to a colleague
The generic ingredient in COLCHICINE is colchicine. There are sixteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the colchicine profile page.
Summary for 203976
Tradename: | COLCHICINE |
Applicant: | Endo Operations |
Ingredient: | colchicine |
Patents: | 0 |
Pharmacology for NDA: 203976
Mechanism of Action | Cytochrome P450 3A4 Inhibitors P-Glycoprotein Interactions |
Medical Subject Heading (MeSH) Categories for 203976
Suppliers and Packaging for NDA: 203976
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
COLCHICINE | colchicine | TABLET;ORAL | 203976 | ANDA | Endo USA, Inc. | 49884-171 | 49884-171-01 | 100 TABLET, FILM COATED in 1 BOTTLE (49884-171-01) |
COLCHICINE | colchicine | TABLET;ORAL | 203976 | ANDA | Endo USA, Inc. | 49884-171 | 49884-171-11 | 30 TABLET, FILM COATED in 1 BOTTLE (49884-171-11) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.6MG | ||||
Approval Date: | Aug 12, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription